What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...

Cancer is often most dangerous when it hides in the early stages. Detecting it before symptoms appear is one of the biggest challenges in modern medicine. Now, researchers from the Korea Institute of ...

PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and ...